Regulators of Life and Death: The Bcl-2 Gene Family

Cellular Physiology and Biochemistry

Volumn 6, Issue 6, 1996, Pages 312-336

  Möröy, Tarik ^a   Zörnis, Martin ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Apoptosis; Bax; Bcl 2; Bcl 2 related genes; Bcl x

Indexed keywords

CALCIUM; PROTEIN BAX;

APOPTOSIS; CARCINOGENESIS; DNA SEQUENCE; GENETIC ANALYSIS; HUMAN; ION TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTO ONCOGENE; REGULATORY MECHANISM; REVIEW;

EID: 0030459311     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000154836     Document Type: Article

References (113)

1. Tsujimoto Y. Finger LR. Tunis J, Nowell PC. Croce CM: Cloning of thechromosomic breakpoint of neoplastic B cells with the t(14:18) chromosome translocation. Science 1984:226:1097-1099.
2. Bakhshi A. Jensen JP. Goldman P. Wright JJ. McBride OW, Epstein AL. Korsmcycr SJ: Cloning the chromosomal break-point of the if 14:18 human lymphomas: Clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 1985:41:889-906.
3. Cleary ML. Smith SD. Sklar J: Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2 immunoglobulin transcript resulting from the t(14:18) translocation. Cell 1986;47:19-28.
4. Vaux Dl. Cory S. Adams TM: Bcl-2 promotes the survival of haemo-poietic cells and cooperates with c-myc to immortalise pre-B cells. Nature 1988:335:440-442.
5. Hockenberv D. Nunez G. Milliman C, Schreibcr RD. Korsmever S: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990: 348:334-336.
6. Wyllie All: Cell death: The significance of apoptosis. Int Rev C'ytol 1980;68:251-306.
7. Scntman CL. Shutter JR, Hockcn-bery D. KanagawaO. Korsmcycr SJ: Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thvmocvtes. Cell 1991:68:879-888. '
8. Strasser A. Harris AW. Cory S: Bel-2 transgenc inhibits T cell death and perturbs thymic self-censorship. Cell 1991:67:889-899.
9. Siegel RM. Katsumata M. Miyashi-ta T. Louie D. Greene ML Reed JC: Inhibition of thymocyte apoptosis and negative antigenic selection in bcl-2 transgenic mice. Prec Natl AcadSei USA 1992:89:7003-7007.
10. Hockenberv DM. Oltvai ZN. Yin XM, Milliman CL. Korsmcycr SJ: Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993:75:241-251.
11. Shimizu S. Eguchi Y. Kosaka H. Kamiike W. Masttda H. Tsujimoto Y: Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature 1995:374:811-813.
12. Zornig M. Bush G. Beneke R. Gul-bins E. Lang F. Ma A. Korsmcycr S. Môroy T: Surv ival and death of pre-lymphomatous B-cells from N-rnyc/ bcl-2 double transgenic mice correlates with the regulation of intracellular Ca++ Duxes. Oncogene 1995: 11:2165-2174.
13. Nunez G. Hockenberry D. McDonnell TJ, Sorensen CM. Korsmeycr SJ: Bcl-2 maintains B cell memory. Nature 1991;353:71-73.
14. Strasscr A. Harris AW, Corcoran LM. Cory S: Bel-2 expression promotes B- but not T-lymphoid development in scid mice. Nature 1994: 368:457-460.
15. McDonnell TJ. Deane N. Plaît FM. Nunez G. Jaeger U. McKeam JP, Korsmcyer SJ: Bcl-2-immunoglobu-lin transgenic mice demonstrate extended B cell survival and follicular lymphoprolifération. Cell 1989:57: 79-88.
16. McDonnell TJ. Korsmcyer SJ: Progression front lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenie for the l(14:18). Nature 1991:349:254-256.
17. Garcia I. Martinou I. Tsujimoto Y, Martinou J-C: Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science 1992:258:302-304.
18. Mah SP. Zhong LT. Wu Y. Roghari A. Edwards RH. Bredescn DE: The protooncogene bcl-2 inhibits apoptosis in PCI2 cells. J Neurochcm 1993:60:1183-1186.
19. Allsopp TE. Wyatt S. Paterson HF. Davies AM: The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell 1993:73:295- 307.
20. Allsopp TE. Kiselev S. Wyatt S. Davies AM: Role of Bcl-2 in the brain-derived neurotrophic factor survival response. Eur J Neurosci 1995:7:1266-1272.
21. Dubois-Dauphin M. Frankowald H. Tsujimoto Y. Huarte J. Martinou JC: Neonatal motoneurons overex-pressing the bcl-2 protooncogene in transgenie mice are protected from axotomy-induced cell death. Proc Natl Acad Sci USA 1994:7:663-698.
22. Martinuou JC. Dubois-Dauphin M. Staple JK. Rodriguez I. Frankowski H. Missottcn M. Albertini P. Tala-bot D. Catsicas S. Pietra C. Huarte J: Ovcrexprcssion of bcl-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 1994:13:1017-1030.
23. Farlie PG. Dringen R. Rees SM. Kannourakis G, Bernard O: Bcl-2 transgene expression can protect neurons against developmental and induced cell death. Proc Natl Acad Sci USA 1995:92:4397-4401.
24. Adams JM. Harris AW. Pinkcrt CA. Corcoran L.M. Alexander WS. Cory
25. S. Palmitcr RD. Brinster RL: The c-mve oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 1985:318:533-538.
26. Strasser A. Harris AW. Bath ML, Cory S: Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature 1990:348:331-333.
27. Merry DE. Vcis DJ. Hickey WF. Korsmcyer S.I: Bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. Development 1994:120: 301-311.
28. Sato N, flotta K. Waguri S. Nitatori T. Tohyama K. Tsujimoto Y. Uchivama Y: Neuronal differentiation of PC 12 cells as a result of prevention of cell death by bcl-2. J Neu-robiol 1994:25:1227-1234.
29. LeBrun DP. Wamke RA, Cleary ML: Expression of bcl-2 in fetal tissues suggests role in morphogenesis. Am J Pathol 1993:142:743-753.
30. Hockcnbcry DM. Zutter M. Hickey W. Nalim M. Korsmcyer SJ Bcl-2 protein is topographically restricted in tissues characterised by apoptotic death. Proc Natl Acad Sci USA 1991:88:6961-6965.
31. Merino R. Ding L. Veis DJ. Korsmcyer SJ. Nunez G: Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes. EMBO J 1994:13:683-691.
32. Linette GP. Grusby MJ. Hedrick SM. Hansen TH, Glimcher l.H. Korsmcyer SJ: Bcl-2 is uprcgulated at theCD4+ CD8+ stage during positive selection and promotes thymocyte differentiation at several control points. Immunity 1994:1:197-205.
33. Chen-Levy Z. Cleary ML: Membrane topology of the Bcl-2 proto-oncogenic protein demonstrated in vitro. J Biol Chem 1990:265 4929-4933.
34. Nguyen M. Millar DG. Yong VW. Korsmeyer SJ. Shore GC: Targeting of Bel-2 to the mitochondrial outer membrane by a COOH-tcrminal signal anchor sequence. J Biol Client 1993:268:25265-25268.
35. Oltvai ZN. Milliman CL. Korsmcyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homologue. Bax. That accelerates programmed cells death. Cell 1993:74:609-619.
36. Jacobson MD. Burne JF. King MP. Miyashita T. Reed JC. Raff MC: Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 1993:361:365-369.
37. Kane DJ, Sarafian TA. Anton R. Hahn H. Gralla EB. Valentine JS. Ord T. Bredescn DE: Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species. Science 1993:262:1274-1277.
38. Jacobson M. RaffMC: Programmed cell death and Bcl-2 protection in very low oxygen. Nature 1995:374: 814-816.
39. Zhong LT, Sarafian T. Kane DJ. Charles AC. Mali SP. Edwards RH. Bredescn DE: Bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci USA 1993:90:4533-4537.
40. Mannhcrz HG. Peitsch MC. Zanotti S. Paddenberg R. Polzar B: A new function for an old enzyme: The role of DNase I in apoptosis. Curr Top Microbiol Immunol 1995:198:161-174.
41. Lam M, Dubyak G, Chen L, Nunez G. Miesfeld RL. Distclhorst CW: Evidence that Bcl-2 represses apoptosis by regulating endoplasmic reticulum-associated Ca + fluxes. Proc Natl Acad Sci USA 1994:91: 6569-6573.
42. Veis DJ, Sorenson CM, Shutter JR. Korsmeyer SJ: Bcl-2-deficienl mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 1993:75: 229-240.
43. Kamada S. Shinto AA. Tsujimura Y. Takahashi T. Noda T. Kitamura Y. Kondoh H, Tsujimoto Y: Bcl-2 deficiency in mice leads to pleiotropic abnormalities: Accelerated lymphoid cell death in the thymus and spleen, polycystic kidney, hair hypopigmentation and distorted small intestine. Cancer Res 1995;55:354-359.
44. Nakayama K-I. Nakayama K. Negi-shi I. Kuida K. Sawa H. Loh DY: Targeted disruption ofbcl-2 beta in mice-occurrence of grey hair, polycystic kidney disease, and lymphocytopenia. Proc Natl Acad Sci USA 1994:91:3700-3704.
45. Sorenson CM. Rogers SA. Kors-mever SJ. Hammerman MR: Fulminant metanephrie apoptosis and abnormal kidney development in bel-2 deficient mice. Am J Physiol 1995: 268:F73-F81.
46. Nakayama Kl. Nakayama K. Negi-shi I. Kuida K. Shinkai Y. Louie MC. Fields LE. Lucas PJ. Stewart V. Alt FW. Loh DY: Disappearance of the lymphoid system in bcl-2 homozygous mutant chimeric mice. Science 1993:261:1584-1588.
47. Michaelidis TM. Sendtner M. Cooper JD. Airaksinen MS. Hollman B. Meyer M. Thocnen H: Inactivation of bcl-2 results in progressive degeneration of motoneurons, sympathetic and sensory neurons during early postnatal development. Neuron 1996:17:75-89.
48. Oltvai ZN. Korsmcyer SJ: Checkpoints of dueling dimers foil death wishes. Cell 1995:79:189-192.
49. Yin XM. Oltvai Z. Korsmcyer SJ: BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and hctcrodimerization with Bax. Nature 1994:369:321-323.
50. Cheng EH-Y. Levine B, Boise LH. Thompson CB. Hardwick JM: Bax-independent inhibition of apoptosis by BcI-xl. Nature 1996:379:554-556.
51. Boyd J. Gallo GJ. Elangovan B. Houghton AB. Malstrom S, Avery BJ. Ebb RG. Subramanian T. Chittenden T. Lutz RJ, Chinnadurai G: Bikl. A novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene 1995;11:1921-1927.
52. Boise LH. Gonzalez-Garcia M. Pos-tema CE. Ding L, Lindsten T. Turka LA, Mao X, Nunez G, Thompson C: Bcl-x. A bcl-2-related gene that functions as a dominant regulator of apoptotic death. Cell 1993:74:597-608.
53. Krajcwski S. Krajewska M. Shabaik A. Miyashita T. Wang HG, Reed JC: Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am .1 Pathol 1994:145:1323-1336.
54. Ma A, Pena JC. Chang B. Margosian E. Davidson L. Alt FW. Thompson CB: Bcl-x regulates the survival of double-positive thymocytes. Proc Natl Acad Sei USA 1995:9295: 4763-4767.
55. Muchmorc SW, Sattler M. Liang H. Meadows RP. Harlan JE, Yoon HS. Nettesheim D. Chang BS. Thompson CS, Wong S-L, Ng S-C. Fcsik SW: X-ray and NMR structure of human Bcl-xL. An inhibitor of programmed cell death. Nature 1996: 381:335-341.
56. Grillot DA, Merino R. Nunez G: Bcl-xi. Displays restricted distribution during T cell development and inhibits multiple forms of apoptosis but not clonal deletion in transgenic mice. J Exp Med 1995:182:1973-1983.
57. Chao DT. Linette GP. Boise LH, White LS, Thompson CB. Kors-meyer SJ: Bcl-xL and Bcl-2 repress a common pathway of cell death. J Exp Med 1995;182:821-828.
58. Motoyama N. Wang F, Roth KA. Sawa H, Nakayama K. Nakayama K. Negishi LScnjuS. ZhangQ. Fujii S. Loh D: Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficiem mice. Science 1995;267:1506-1510.
59. Chen J. Shinkai Y. Young F. Alt FW: Probing immune functions in RAG-deficient mice. CurrOpin Immunol 1994:6:313-319.
60. Lin EY. Orlofsky A. Berger MS. Prystowsky MB: Characterisation of Al. A novel hemopoietic-specific early response gene with sequence similarity to bcl-2. J Immunol 1993: 151:1979-1988.
61. Lin EY, Orlofsky A. Wang HG. Reed JC. Prystowsky MB: A I, a Bcl-2 family member, prolongs cell survival and permits myeloid differentiation. Blood 1996:87:983-992.
62. Gibson L. Holmgreen SP. Huang DCS. Bernard O. Copeland NG. Jenkins NA. Sutherland GR. Baker E. Adams JM, Cory S: Bcl-w.a novel member of the bcl-2 family, promotes cell survival. Oncogene 1996; 13:665-675.
63. Kozopas KM, Yang T. Buchan HI. Zhou P. Craig RW: MCL1, a gene expressed in programmed myeloid differentiation, has sequence similarity to Bcl-2. Proc Nall Acad Sei USA 1993:90:3516-3520.
64. Reynolds JE. Yang T, Qian L. Jcn-kinson JD. Zhou P. Eastman A. Craig RW: Mcl-1. A member of the Bcl-2 family, delays apoptosis induced by c-Myc overexpression in Chinese hamster ovary cells. Cancer Res 1994:54:6348-6352.
65. Choi SS. Park IC. Yun JW, Sung YC, Hong SI. Shin HS: A novel Bcl-2 related gene. Bfl-1. Is overexpressed in stomach cancer and preferentially expressed in bone marrow. Oncogene 1996:11:1693-1698.
66. Das R. Reddy EP. Chatterjee D. Andrews DW: Identification of a novel Bcl-2 related gene. BRAG-1, in human glioma. Oncogene 1996:12: 947-951.
67. White E. Sabbatini P, Debbas M, Wold WS. Kusher DL Gooding LR: The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cy-tolysis by tumor necrosis factor alpha. Mol Cell Biol 1992:12:2570-2580.
68. Boyd J. Malstrom S. Subramanian T. Venkatesh L. Schacper U. Elangovan B. D'Sa-Eippcr C. Chinnadurai G: Adenovirus EIB 19KdA and bcl-2 proteins interact with a common set of cellular proteins. Cell 1994;79:341-351.
69. Neilan JG. Lu Z. Afonso CL, Kutish GF. Sussman MD. Rock DL: An African swine fever virus gene with similarity to the proto-oncogene bcl-2 and the Epstcin-Barr virus gene BHRF1. J Virol 1993:67:4391-4394.
70. Henderson S. Huen D. Rowe M, Dawson C. Johnson G. Rickinson A: Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2. Protects human B cells from programmed cell death. Proc Natl Acad Sci USA 1993:90:8479-8483.
71. Sato T. Hanada M. Bodrug S. Irie S. Iwama N. Boise L. Thompson CB. Golcmis E. Fong L. W'ang H-G, Reed JC: Interactions among members of the Bcl-2 family analyzed with a yeast two-hybrid system. Proc Natl Acad Sci USA 1994:91:9238-9242.
72. Han J, Sabbalini P, Perez D. Rao L. Modha D. White H: The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-indueiblc and death-promoting Bax protein. Genes Dev 1996; 10:461 - 477.
73. Yang E. Zha J. Jockel J. Boise LH, Thompson CB. Korsmeyer SJ: Bad. A heterodinreric partner for Bcl-xL and Bcl-2. Displaces Bax and promotes cell death. Cell 1995:80:285-291.
74. Chittenden T, Harrington EA, O'Connor R. Fiemington C. Lutz RJ. Evan GI. Guild BC: Induction of apoptosis by the Bcl-2 homologue Bak. Nature 1995:374:733-736.
75. Brady HJM, Salomons GS, Bobel-dijk RC. Bcrns AJM: T cells from bax alpha transgenic mice show accelerated apoptosis in response to stimuli but do not show restored DNA damage-induced cell death in the absence of p53. EMBO J 1996: 15:1221-1230.
76. Kitada S. Krajewski S. Miyashita T. Krajewska M. Reed JC: g-Radiation induces uprcgulation of Bax protein and apoptosis in radiosensitive cells in vivo. Oncogene 1996:12:187-192.
77. Knudson CM, Tung KSK. Tourtcl-lotte WG, Brown GAJ, Korsnteyer SJ: Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 1995:270:96-99.
78. Greenhalf W. Stephan C. Chaudhu-ri B: Role of mitochondria and C-terminal membrane anchor of Bcl-2 in Bax induced growth arrest and mortality in Saccharomyces cere\i-siae. FEBS Lett 1996:380:169-175.
79. Ameisen J: The origin of programmed cell death. Science 1996: 272:1278-1279.
80. Kiefer MC. Brauer MJ, Powers VC. Wu JJ, Umanskv SR. Tomei LD, Barr PJ: Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 1995:374:736- 739.
81. Farrow SN. White JHM. Martinou I, Raven T. Pun K-T. Grinham CJ. Martinou J-C. Brown R: Cloning of a bcl-2 homologue by interaction with adenovirus E1B I9K. Nature 1995:374:731-733.
82. Krajewski S. Krajewska M. Reed JC: Immunohistochemical analysis of in vivo patterns of Bak expression. A proapoptotic member of the Bcl-2 protein family. Cancer Res 1996:56:2849-2855.'
83. Krajewska M. Moss SF. Krajewski S. Song K. Holt PR. Reed JC: Elevated expression of Bcl-x and reduced Bak in primary colorectal adenocarcinomas. Cancer Res 1996: 56:2422-2427.
84. McCarthy NJ: Apoptosis: A Review. Scrip Reports. PJB Publications. 1996.
85. Takayama S. Sato T, Krajewski S. Kochel K. Irie S, Millan JA. Reed JC: Cloning and functional analysis of BAG-1: A novel Bcl-2-binding protein with anti-cell death activity. Cell 1995:80:279-284.
86. Délie J. Morange M, Magdelcnat H: Ubiquilin pathway involvement in human lymphocyte gamma-irradiation-induced apoptosis. Mol Cell Biol 1993:13:4875-4883.
87. Wang H-G. Takayama S. Rapp U. Reed JC: Bcl-2 interacting protein. Bag-1, binds to and activates the kinase Raf-t. Proc Natl Acad Sci USA 1996:93:7063-7068.
88. Askew DS. Ashmun RA, Simmons BC. Cleveland JL: Constitutive c-myc expression in an IL-3-depcn-dent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 1991:6:1915-1922.
89. Evan GI, Wyllie AH. Gilbert CS, Littlewood TD. Land H, Brooks M, Waters CM. Penn LZ. Hancock DC: Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992:69:119-128.
90. Bennett MR. Evan GI. Newby AC: Deregulated expression of the c-myc oncogene abolishes inhibition of proliferation of rat vascular smooth muscle cells by scrum reduction, interferon-gamma. heparin, and cyclic nucleotide analyogucs and induces apoptosis. Circ Res 1994:74:525- 536.
91. Bissonnette RP. Echeverri F. Mah-boubi A. Green D: Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 1992:359:552- 554.
92. Fanidi A, Harrington EA. Evan G: Cooperative interaction between c-myc and bcl-2 proto-oncogene. Nature 1992;359:554-556.
93. Harrington EA. Bennett MR. Fa-nidi A. Evan GI: C-Myc-induccd apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J 1994; 13:3286-3295.
94. Femandez-Sarabia MJ. Bischof TJR: Bcl-2 associates with the ras-rclated protein R-ras p23. Nature 1993:366:274-275.
95. Lin H-JL. Eivner V. Prendcrgast GC, White E: Activated H-ras rescues ElA-induced apoptosis and cooperates with El A to overcome p53-dependent growth arrest. Mol Cell Biol 1995; 15:4536-4544.
96. Wang H-G. Milan JA. Cox AD. Der CJ, Rapp UR, Beck T, Zha H. Reed JC: R-ras promotes apoptosis caused by growth factor deprivation via a Bcl-2 supprcssible mechanism. J Cell Biol 1995:129: 1103-1114.
97. Mercer WE. Shields MT, Amin M. Sauve GJ. Appella E. Romano J W. Ullrich SJ: Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc Natl Acad Sci USA 1990:87:6166-6170.
98. Miyashita T. Krajewski S. Krajewska M. Wang HG. Lin HK. Lie-bermann DA. Hoffman B. Reed JC: Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994;9:1799-1805.
99. Miyashita T. Reed JC: Tumor suppressor p53 is a direct transcriptional activator of human bax gene. Cell 1995:80:293-299.
100. Miyashita T. Harigai M. Hanada M. Reed JC: Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 1995:54:3131-3135.
101. Symonds H. Krail L. Remington L. Saenz-Roblcs M. Lowe S. Jacks T. Van Dyke T: P53-dcpendcnt apoptosis suppresses tumor growth and progression in vivo. Cell 1994: 78:703-711.
102. El-Dciry WS. Tokino T. Vclculcs-cu VE, Levy DB, Parsons R. Trent JM. Lin D. Mercer WE, Kinzler KW. Vogelstein B: WAF1. A potential mediator of p53 tumor suppression. Cell 1993;75:817-825.
103. Harper JW. Adami GR. Wei N. Keyomarsi K, Elledge SJ: The p21 CDK-intcracting protein Cipl is a potent inhibitor of G! cyclin-de-pendent kinases. Cell 1993:75: 805-816.
104. Caches C. Helmberg A. Karin M: p53-dependenl apoptosis in the absence of transcriptional activation of p53-target genes. Nature 1994;370:220-223.
105. White E: Life, death, and the pursuit of apoptosis. Genes Dev 1996; 10:1-15.
106. Flaws JA. Kugu K. Trbovich AM. DeSanti A. Tilly Kl. Hirshficld AN, Tilly JL: Interleukin-1 betaconverting enzyme-related proteases (IRPs) and mammalian cell death: Dissociation of IRP-in-duccd oligonuclcosomal endonuclease activity from morphological apoptosis in granulosa cells of the ovarian follicle. Endocrinology 1995:136:5042-5053.
107. W'ang X. Pai JT. Wicdcnfeld EA. Medina JC. Slaughter CA. Goldstein JL, Brown MS: Purification of an interleukin-1 beta converting enzyme-related cystcineprotease that cleaves sterol regulatory element-binding proteins between the leucine zipper and transmembranc domains. J Biol Chcm 1995:270: 18044-18050.
108. Munday NA. Vaillancourt JP. Ali A. Casano FJ. Miller DK. Moli-ncaux SM. Yamin TT, Yu VL, Nicholson DW: Molecular cloning and pro-apoptotic activity of ICErelll and ICErclIII. members of the 1CE/CED-3 family of cysteine proteases. J Biol Client 1995: 270:15870-15876.
109. Ellis HM. Horvitz HR: Genetic control of programmed cel! death in the nematode C. elegans. Cell 1980:44:817-829.
110. Armstrong RC. Aja T. Xiang J. Gaur S. Krebs JF. Hoang K. Bai X. Korsmcycr SJ. Karanewsky DS. Fritz LC. Tomaselli KJ: Fas-in-duced activation of the cell death related protease CPP32 is inhibited by Bcl-2 and by ICE family protease inhibitors. J Biol Chem 1996: 271:16850-16855.
111. Shimizu S. Eguchi Y. Kamiikc W. Matsuda H. Tsujimoto Y: Bcl-2 expression prevents activation of the ICE protease cascade. Oncogene 1996; 12:2251-2257.
112. Strasser A. Harris AW. Huang DC. Krammcr PH. Cory S: Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EM BO J 1996:14:6136-6147.
113. Ryan JJ. Prochownik E. Gottlieb CA, Apc I-J. Merino R. Nunez G. Clarke MF: C-myc and bcl-2 modulate p53 function by altering p53 subccllular trafficking during the cell cvcle. Proc Nall Acad Sci USA 1994:91:5878-5882.